At the news
? NEUTRALIMPACT 5/10 EFFECT filed Nov 18, 2026 at 00:15 ET
The SEC declared Medline Inc.'s S-1 registration statement (File No. 333-300065) effective on November 17, 2026. This clears the way for a secondary offering of 60 million shares by selling stockholders and a concurrent $200 million share repurchase by the company, as detailed in the prior S-1 filing. The company receives no proceeds from the offering.
- Effectiveness date: November 17, 2026
- Registration statement File No. 333-300065 declared effective
- Underlying S-1 (filed Nov 16, 2026) covers secondary offering of 60M shares by selling stockholders
- Concurrent $200M repurchase of shares and units is conditioned on the offering closing
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access